Search results
From Proteopedia
You searched for Inhibitory_Concentration_.28IC50.29
There is no page with the exact title "Inhibitory_Concentration_.28IC50.29". The search results for "Inhibitory_Concentration_.28IC50.29" are displayed below. You can create a page titled Inhibitory_Concentration_.28IC50.29 (by clicking on the red link).
For more information about searching Proteopedia, see Help.
Showing below 10 results starting with #1.
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
No page title matches
Page text matches
- Statin Pharmacokinetics (1,335 bytes)
29: ! [[Pharmacokinetics#Bioavailability_.28F.29|Bioavailability]] (%)
31: ! 19-29
45: ! [[Pharmacokinetics#Half_Life_.28T1.2F2.29|T<sub>1/2</sub>]] (hr)
53: ! [[Pharmacokinetics#Area_Under_the_Curve_.28AUC.29|AUC]] (ng/ml/hr)
61: ...Pharmacokinetics#Inhibitory_Concentration_.28IC50.29|IC<sub>50</sub>]] (nM) - ACE Inhibitor Pharmacokinetics (1,339 bytes)
32: ! [[Pharmacokinetics#Bioavailability_.28F.29|Bioavailability]] (%)
50: ! [[Pharmacokinetics#Half_Life_.28T1.2F2.29|T<sub>1/2</sub>]] (hr)
59: ! [[Pharmacokinetics#Area_Under_the_Curve_.28AUC.29|AUC]] (ng/ml/hr)
68: ...Pharmacokinetics#Inhibitory_Concentration_.28IC50.29|IC<sub>50</sub>]] (nM) - Tositumomab (1,231 bytes)
24: ! [[Pharmacokinetics#Bioavailability_.28F.29|Bioavailability]] (%)
30: ! [[Pharmacokinetics#Half_Life_.28T1.2F2.29|T<sub>1/2</sub>]] (hr)
36: ! [[Pharmacokinetics#Area_Under_the_Curve_.28AUC.29|AUC]] (ng/ml/hr)
38: ! 32939000
42: ! [[Pharmacokinetics#Clearance_.28Cl.29|Clearance]] (L/h) - Dipeptidyl Peptidase-4 Inhibitor Pharmacokinetics (1,251 bytes)
16: ! 290
20: ! [[Pharmacokinetics#Bioavailability_.28F.29|Bioavailability]] (%)
30: ! [[Pharmacokinetics#Half_Life_.28T1.2F2.29|T<sub>1/2</sub>]] (hr)
35: ! [[Pharmacokinetics#Area_Under_the_Curve_.28AUC.29|AUC]] (ng/ml/hr)
40: ...Pharmacokinetics#Inhibitory_Concentration_.28IC50.29|IC<sub>50</sub>]] (nM) - Bevacizumab (2,325 bytes)
30: ! [[Pharmacokinetics#Bioavailability_.28F.29|Bioavailability]] (%)
33: ! [[Pharmacokinetics#Half_Life_.28T1.2F2.29|T<sub>1/2</sub>]] (days)
36: ! [[Pharmacokinetics#Area_Under_the_Curve_.28AUC.29|AUC]] (ug/ml/hr)
39: ...Pharmacokinetics#Inhibitory_Concentration_.28IC50.29|IC<sub>50</sub>]] (nM)
42: ! [[Pharmacokinetics#Clearance_.28Cl.29|Clearance]] (L/h) - Sunitinib (3,575 bytes)
13: ...Pharmacokinetics#Inhibitory_Concentration_.28IC50.29|IC<sub>50</sub>]] for Sunitinib is 40nM for inact... - NSAID Pharmacokinetics (3,873 bytes)
56: ! [[Pharmacokinetics#Bioavailability_.28F.29|Bioavailability]] (%)
90: ! [[Pharmacokinetics#Half_Life_.28T1.2F2.29|T<sub>1/2</sub>]] (hr)
107: ! [[Pharmacokinetics#Area_Under_the_Curve_.28AUC.29|AUC]] (ng/ml/hr)
124: ...Pharmacokinetics#Inhibitory_Concentration_.28IC50.29|IC<sub>50</sub>]] COX-1 (nM) in Whole Blood
133: ! 2900 - Acetylcholinesterase Inhibitor Pharmacokinetics (1,187 bytes)
20: ! 29.3
23: ! [[Pharmacokinetics#Bioavailability_.28F.29|Bioavailability]] (%)
35: ! [[Pharmacokinetics#Half_Life_.28T1.2F2.29|T<sub>1/2</sub>]] (hr)
41: ! [[Pharmacokinetics#Area_Under_the_Curve_.28AUC.29|AUC]] (ng/ml/hr)
47: ...Pharmacokinetics#Inhibitory_Concentration_.28IC50.29|IC<sub>50</sub>]] (nM) - Glitazone Pharmacokinetics (998 bytes)
19: ! [[Pharmacokinetics#Bioavailability_.28F.29|Bioavailability]] (%)
27: ! [[Pharmacokinetics#Half_Life_.28T1.2F2.29|T<sub>1/2</sub>]] (hr)
31: ! [[Pharmacokinetics#Area_Under_the_Curve_.28AUC.29|AUC]] (ng/ml/hr)
35: ...Pharmacokinetics#Inhibitory_Concentration_.28IC50.29|IC<sub>50</sub>]] (nM) - Sitagliptin (3,135 bytes)
12: ...Pharmacokinetics#Inhibitory_Concentration_.28IC50.29|IC<sub>50</sub>]]: 18 nM vs. >50,000 nM for other...
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)